Did a change of glucagon derail the Inreda artificial pancreas trial?
Inreda’s recent year long study on their dual hormone AID system didn’t produce the results anyone wanted. Here we dig into that further.
glucagon
Zucara’s ZT-01: what could taking the brake off glucagon do?
ZT-01 aims to restore glucagon counterregulation during hypoglycaemia. But type 1 diabetes already produces glucagon at the wrong time — and Zucara’s own human data show SSTR2 blockade raises glucagon, glucose and insulin requirements during euglycaemia. What will the trials tell us about its longer term effects?
GLP1-RAs in Type 1 Diabetes: more than meets the eye?
Some people will be aware, and some not, that there is a reasonable minority of people with Type 1 Diabetes using GLP-1 Receptor Agonists (GLP1-RAs) […]
Glucagon me… n=1 experiments with microbolusing glucagon part 2: quantifying use
Are two hormones and an algorithm enough? Or is diabetes far more complex than that?
Glucagon me… n=1 experiments with microbolusing Glucagon part 1: setting a baseline
Everyone with type 1 is taught that the big orange plastic box that we’re supposed to keep in the fridge is for emergencies only and […]